N-(4-Hydroxynaphthalen-1-yl)-2,4-dimethylbenzenesulfonamide

Catalog No. :
ACYEFU867
CAS No. :
333351-38-5
Molecular Formula :
C18H17NO3S
Molecular Weight :
327.40

IUPAC Name:N-(4-hydroxynaphthalen-1-yl)-2,4-dimethylbenzenesulfonamide

N-(4-Hydroxynaphthalen-1-yl)-2,4-dimethylbenzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$70.00Login to see priceInquiryInquiry
5mg98%$167.00Login to see priceInquiryInquiry
10mg98%$268.00Login to see priceInquiryInquiry
25mg98%$455.00Login to see priceInquiryInquiry
50mg98%$652.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-Hydroxynaphthalen-1-yl)-2,4-dimethylbenzenesulfonamide
IUPAC NameN-(4-hydroxynaphthalen-1-yl)-2,4-dimethylbenzenesulfonamide
Molecular FormulaC18H17NO3S
Molecular Weight327.40
SMILESO=S(C1=CC=C(C)C=C1C)(NC2=C3C=CC=CC3=C(O)C=C2)=O
InChI KeyBUAHBIAKRIDOHI-UHFFFAOYSA-N
SynonymN-(4-hydroxy-1-naphthyl)-2,4-dimethylbenzenesulfonamide;Benzenesulfonamide, N-(4-hydroxy-1-naphthalenyl)-2,4-dimethyl-;ATG12-ATG3 inhibitor 189,;ATG12-ATG3 inhibitor 1
CAS No.333351-38-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACYEFU867 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYEFU867 route product structure diagram
    ACYEFU867333351-38-5
Inquiry

2. ACYEFU867 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYEFU867 route product structure diagram
    ACYEFU867333351-38-5
Inquiry

Comments (0)